Perfil
Laura Saward formerly worked at Cangene Corp., as Chief Scientific Officer from 2012 to 2014, Emergent BioSolutions, Inc., as SVP & Antibody Therapeutics Business Unit from 2017 to 2021, and Manitoba Health Research Council, as Member.
Dr. Saward received her undergraduate degree from the University of Guelph and doctorate degree from the University of Manitoba.
Antiguos cargos conocidos de Laura Saward.
| Empresas | Cargo | Fin |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/10/2021 |
| CANGENE CORPORATION | Chief Tech/Sci/R&D Officer | 01/04/2014 |
| Manitoba Health Research Council | Corporate Officer/Principal | - |
Formación de Laura Saward.
| University of Guelph | Undergraduate Degree |
| University of Manitoba | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
| Manitoba Health Research Council |
- Bolsa de valores
- Insiders
- Laura Saward
